PANK2 (Q9BZ23) variants and mutations
PANK2 (also known as Q9BZ23) is a human protein-coding gene encoding a pantothenate kinase 2, mitochondrial protein. Its annotated function is mitochondrial isoform that catalyzes the phosphorylation of pantothenate to generate 4'-phosphopantothenate in the first and rate-determining step of coenzyme A (CoA) synthesis. It is annotated at the mitochondrion. This analysis covers 611 PANK2 variants and mutations. Of these, 100% have computational variant effect predictions. Disease context includes pantothenate kinase-associated neurodegeneration, hypoprebetalipoproteinemia, acanthocytosis, retinitis pigmentosa, and pallidal d, and dystonic disorder. Example PANK2 variants include M1M, M1V, and M1L.
Variant analysis overview
- Gene: PANK2
- Protein: Q9BZ23
- UniProt accession: Q9BZ23
- Organism: Homo sapiens
- Variants analyzed: 611
- Variant scope: all variants
- Completed: 2026-10-30
Variant and mutation evidence
- Variant composition: 201 unspecified-consequence records; 322 missense variants; 88 synonymous variants; 36 frameshift variants; 1 in-frame insertions; 14 stop-gained variants; 6 in-frame deletions; 1 protein altering variant; 5 substitution
- Prediction scores: 615 variants have prediction scores (101% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: pantothenate kinase-associated neurodegeneration, hypoprebetalipoproteinemia, acanthocytosis, retinitis pigmentosa, and pallidal d, dystonic disorder, hereditary disease, neurodegeneration with brain iron accumulation, retinitis pigmentosa, Neurodegeneration, inherited retinal dystrophy, classic pantothenate kinase-associated neurodegeneration, atypical pantothenate kinase-associated neurodegeneration, cone-rod dystrophy, Rubinstein-Taybi syndrome due to EP300 haploinsufficiency.
Protein structure and variant hotspots
- Protein features: 3 binding sites; 3 post-translational modification sites.
- PTM context: 1 variants overlap post-translational modification sites.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, Interaction Network Analysis, Protein Data Bank, AlphaFold DB, gnomAD constraint, Open Targets, MaveDB, LitVar.
Notable PANK2 variants
Examples include M1M, M1V, M1L, M1K, M1T, M1R, M1I, M1W. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- M1M (p.Met1Met), rs983462252, gnomAD 20-3889431-C-A, AlphaMissense 0.10, MetaLR 0.86
- M1V (p.Met1Val), rs1368727421, gnomAD 20-3889470-A-G, REVEL 0.52, ESM-1b 0.00
- M1L (p.Met1Leu), gnomAD 20-3889470-A-C, REVEL 0.52, ESM-1b 0.00
- M1K (p.Met1Lys), gnomAD 20-3889471-T-A, REVEL 0.57, ESM-1b 0.20
- M1T (p.Met1Thr), gnomAD 20-3889471-T-C, REVEL 0.55, ESM-1b 0.00
- M1R (p.Met1Arg), gnomAD 20-3889471-T-G, REVEL 0.58, ESM-1b 0.00
- M1I (p.Met1Ile), rs1232851079, gnomAD 20-3889472-G-A, REVEL 0.42, ESM-1b 0.56
- M1W (p.Met1Trp), gnomAD 20-3889492-CG-C, CADD 24.40
- R2G (p.Arg2Gly), rs2090063082, gnomAD 20-3889104-A-G, REVEL 0.32, ESM-1b 0.00
- R2K (p.Arg2Lys), gnomAD 20-3889105-G-A, REVEL 0.20, ESM-1b 0.00
- R2S (p.Arg2Ser), rs2090063124, gnomAD 20-3889106-G-T, REVEL 0.32, ESM-1b 0.00
- R2R (p.Arg2Arg), gnomAD 20-3889106-G-A, CADD 7.00
- R3S (p.Arg3Ser), rs1211425299, ClinGen CA408138126, ClinVar RCV000687659, ClinVar RCV002544786, REVEL 0.18, ESM-1b 0.00, Uncertain significance, Inborn genetic diseases; not provided; Pigmentary pallidal degeneration
- R3R (p.Arg3Arg), gnomAD 20-3889107-A-C, CADD 7.85
- R3G (p.Arg3Gly), gnomAD 20-3889107-A-G, REVEL 0.18, ESM-1b 0.00
- R3W (p.Arg3Trp), gnomAD 20-3889107-A-T, REVEL 0.28, ESM-1b 0.00
- R3K (p.Arg3Lys), gnomAD 20-3889108-G-A, REVEL 0.13, ESM-1b 0.00
- L4R (p.Leu4Arg), rs1270981339, gnomAD 20-3889111-T-G, REVEL 0.22, ESM-1b 0.00
- L4L (p.Leu4Leu), gnomAD 20-3889112-C-G, CADD 3.46
- L4M (p.Leu4Met), rs2090073781, gnomAD 20-3889440-T-A, REVEL 0.29, ESM-1b 0.00
- L4* (p.Leu4Ter), gnomAD 20-3889441-T-A, CADD 37.00
- L4S (p.Leu4Ser), rs2090073827, gnomAD 20-3889441-T-C, REVEL 0.41, ESM-1b 0.00
- L4F (p.Leu4Phe), rs1361098976, gnomAD 20-3889442-G-T, REVEL 0.30, ESM-1b 0.00
- L4I (p.Leu4Ile), gnomAD 20-3889443-C-A, REVEL 0.38, ESM-1b 0.00
- L4V (p.Leu4Val), gnomAD 20-3889443-C-G, REVEL 0.32, ESM-1b 0.00
- L4P (p.Leu4Pro), gnomAD 20-3889444-T-C, REVEL 0.55, ESM-1b 0.00
- G5E (p.Gly5Glu), rs748405977, ClinGen CA9750455, ClinVar RCV002629673, REVEL 0.17, ESM-1b 0.00, Uncertain significance, Pigmentary pallidal degeneration
- G5R (p.Gly5Arg), gnomAD 20-3889113-G-C, REVEL 0.19, ESM-1b 0.00
- G5V (p.Gly5Val), gnomAD 20-3889114-G-T, REVEL 0.23, ESM-1b 0.00
- G5G (p.Gly5Gly), gnomAD 20-3889115-G-T, CADD 4.14
- G5W (p.Gly5Trp), rs575187605, gnomAD 20-3889434-G-T, REVEL 0.60, ESM-1b 0.00
- G5A (p.Gly5Ala), gnomAD 20-3889435-G-C, REVEL 0.47, ESM-1b 0.00
- G5S (p.Gly5Ser), rs1432572102, gnomAD 20-3889437-G-A, REVEL 0.33, ESM-1b 0.00
- G5C (p.Gly5Cys), gnomAD 20-3889437-G-T, REVEL 0.41, ESM-1b 0.00
- G5D (p.Gly5Asp), rs1268207892, gnomAD 20-3889438-G-A, REVEL 0.52, ESM-1b 0.00
- P6S (p.Pro6Ser), gnomAD 20-3889116-C-T, REVEL 0.17, ESM-1b 0.00
- P6L (p.Pro6Leu), rs1644304107, gnomAD 20-3889117-C-T, REVEL 0.20, ESM-1b 0.00
- P6P (p.Pro6Pro), gnomAD 20-3889118-C-T, CADD 5.38
- F7S (p.Phe7Ser), rs1459133770, gnomAD 20-3889120-T-C, REVEL 0.16, ESM-1b 0.00
- F7C (p.Phe7Cys), rs1459133770, gnomAD 20-3889120-T-G, REVEL 0.19, ESM-1b 0.00
- F7L (p.Phe7Leu), rs1430366292, gnomAD 20-3889121-C-A, REVEL 0.18, ESM-1b 0.00
- H8Y (p.His8Tyr), rs1180369007, gnomAD 20-3889122-C-T, REVEL 0.23, ESM-1b 0.00
- H8P (p.His8Pro), gnomAD 20-3889123-A-C, REVEL 0.24, ESM-1b 0.00
- H8Q (p.His8Gln), rs1216238658, gnomAD 20-3889124-C-A, REVEL 0.14, ESM-1b 0.00
- H8H (p.His8His), rs1216238658, gnomAD 20-3889124-C-T, CADD 9.02
- P9H (p.Pro9His), rs1351574207, gnomAD 20-3889123-AC-A, CADD 22.30
- P9S (p.Pro9Ser), gnomAD 20-3889125-C-T, REVEL 0.19, ESM-1b 0.00
- P9L (p.Pro9Leu), rs1356157885, gnomAD 20-3889126-C-T, REVEL 0.29, ESM-1b 0.00
- P9Q (p.Pro9Gln), gnomAD 20-3889126-C-A, REVEL 0.28, ESM-1b 0.00
- P9P (p.Pro9Pro), rs529957037, gnomAD 20-3889127-A-C, CADD 11.30
- R10S (p.Arg10Ser), gnomAD 20-3889128-C-A, REVEL 0.21, ESM-1b 0.00
- R10C (p.Arg10Cys), gnomAD 20-3889128-C-T, REVEL 0.23, ESM-1b 0.00
- R10G (p.Arg10Gly), gnomAD 20-3889128-C-G, REVEL 0.21, ESM-1b 0.00
- R10L (p.Arg10Leu), rs1473379200, gnomAD 20-3889129-G-T, REVEL 0.18, ESM-1b 0.00
- R10H (p.Arg10His), rs1473379200, gnomAD 20-3889129-G-A, REVEL 0.20, ESM-1b 0.00
- R10R (p.Arg10Arg), rs541722188, gnomAD 20-3889130-C-T, CADD 8.86
- R10W (p.Arg10Trp), gnomAD 20-3889449-C-T, REVEL 0.64, ESM-1b 0.00
- R10Q (p.Arg10Gln), rs911560228, gnomAD 20-3889450-G-A, REVEL 0.51, ESM-1b 0.00
- R10* (p.Arg10Ter), rs944348405, gnomAD 20-3889455-C-T, CADD 39.00
- R10P (p.Arg10Pro), gnomAD 20-3889456-G-C, REVEL 0.58, ESM-1b 0.00
- V11I (p.Val11Ile), rs886044063, gnomAD 20-3889131-G-A, REVEL 0.26, ESM-1b 0.00
- V11A (p.Val11Ala), rs865807872, gnomAD 20-3889132-T-C, REVEL 0.28, ESM-1b 0.00
- V11V (p.Val11Val), gnomAD 20-3889133-C-G, CADD 11.00
- H12Y (p.His12Tyr), rs374286033, ClinGen CA9750457, ClinVar RCV001203887, ClinVar RCV003994233, REVEL 0.32, ESM-1b 0.00, Conflicting interpretations, Inborn genetic diseases; not specified; Pigmentary pallidal degeneration
- H12P (p.His12Pro), gnomAD 20-3889135-A-C, REVEL 0.37, ESM-1b 0.00
- H12L (p.His12Leu), gnomAD 20-3889135-A-T, REVEL 0.34, ESM-1b 0.00
- H12R (p.His12Arg), rs761235861, gnomAD 20-3889135-A-G, REVEL 0.29, ESM-1b 0.00
- H12Q (p.His12Gln), gnomAD 20-3889136-T-A, REVEL 0.34, ESM-1b 0.00
- H12H (p.His12His), rs2090064000, gnomAD 20-3889136-T-C, CADD 10.60
- W13* (p.Trp13Ter), rs2515419501, ClinGen CA408138399, ClinVar RCV002599153, ClinVar RCV004818226, CADD 19.06, Pathogenic
- W13R (p.Trp13Arg), rs971003044, ClinGen CA9750460, ClinVar RCV000800323, ClinVar RCV004028022, REVEL 0.39, ESM-1b 0.00, Uncertain significance, Inborn genetic diseases; Pigmentary pallidal degeneration
- W13G (p.Trp13Gly), rs971003044, gnomAD 20-3889137-T-G, REVEL 0.47, ESM-1b 0.00
- W13L (p.Trp13Leu), gnomAD 20-3889138-G-T, REVEL 0.42, ESM-1b 0.00
- W13C (p.Trp13Cys), rs2090064190, gnomAD 20-3889139-G-T, REVEL 0.49, ESM-1b 0.00
- A14R (p.Ala14Arg), rs766448021, gnomAD 20-3889137-TG-T, CADD 26.40
- A14S (p.Ala14Ser), rs766040462, gnomAD 20-3889140-G-T, REVEL 0.44, ESM-1b 0.00
- A14T (p.Ala14Thr), rs766040462, gnomAD 20-3889140-G-A, REVEL 0.47, ESM-1b 0.00
- A14E (p.Ala14Glu), gnomAD 20-3889141-C-A, REVEL 0.46, ESM-1b 0.00
- A14V (p.Ala14Val), rs1401923962, gnomAD 20-3889141-C-T, REVEL 0.36, ESM-1b 0.00
- A14A (p.Ala14Ala), rs1389176309, gnomAD 20-3889142-G-A, CADD 12.80
- A15T (p.Ala15Thr), rs760822872, gnomAD 20-3889136-TTGGGC, CADD 27.80
- p.Ala15dup, gnomAD 20-3889138-G-GGGC, CADD 20.70
- A15E (p.Ala15Glu), gnomAD 20-3889144-C-A, REVEL 0.32, ESM-1b 0.00
- A15G (p.Ala15Gly), gnomAD 20-3889144-C-G, REVEL 0.28, ESM-1b 0.00
- A15V (p.Ala15Val), rs759331809, gnomAD 20-3889144-C-T, REVEL 0.34, ESM-1b 0.00
- A15A (p.Ala15Ala), gnomAD 20-3889145-G-C, CADD 13.90
- p.Ala21 Gly27del, rs2090075768, gnomAD 20-3889486-TCGGCG, CADD 21.90
- A15F (p.Ala15Phe), gnomAD 20-3889489-G-GTTT, CADD 24.50
- A15S (p.Ala15Ser), gnomAD 20-3889491-G-T, REVEL 0.20, ESM-1b 0.00
- A15P (p.Ala15Pro), gnomAD 20-3889491-G-C, REVEL 0.28, ESM-1b 0.00
- A15D (p.Ala15Asp), gnomAD 20-3889516-C-A, REVEL 0.28, ESM-1b 0.00
- A15R (p.Ala15Arg), gnomAD 20-3889518-T-TC, CADD 23.80
- P16S (p.Pro16Ser), rs1483678197, gnomAD 20-3889146-C-T, REVEL 0.29, ESM-1b 0.00
- P16L (p.Pro16Leu), rs2090064466, gnomAD 20-3889147-C-T, REVEL 0.32, ESM-1b 0.00
- P16P (p.Pro16Pro), rs982359150, gnomAD 20-3889148-G-A, CADD 12.90
- P17T (p.Pro17Thr), gnomAD 20-3889149-C-A, REVEL 0.41, ESM-1b 0.00
- P17L (p.Pro17Leu), rs1291249355, gnomAD 20-3889150-C-T, REVEL 0.41, ESM-1b 0.00
- P17R (p.Pro17Arg), gnomAD 20-3889150-C-G, REVEL 0.40, ESM-1b 0.00
- P17P (p.Pro17Pro), gnomAD 20-3889151-A-G, CADD 14.60
- P17S (p.Pro17Ser), gnomAD 20-3889494-C-T, REVEL 0.24, ESM-1b 0.00
- P17A (p.Pro17Ala), gnomAD 20-3889494-C-G, REVEL 0.25, ESM-1b 0.00
- P17H (p.Pro17His), rs1329524108, gnomAD 20-3889495-C-A, REVEL 0.29, ESM-1b 0.00
- S18T (p.Ser18Thr), gnomAD 20-3889152-T-A, REVEL 0.38, ESM-1b 0.00
- S18L (p.Ser18Leu), gnomAD 20-3889153-C-T, REVEL 0.43, ESM-1b 0.00
- S18* (p.Ser18Ter), gnomAD 20-3889153-C-A, CADD 20.90
- S18S (p.Ser18Ser), rs886056650, gnomAD 20-3889154-A-G, CADD 8.24
- L19F (p.Leu19Phe), rs1568549056, ClinGen CA408138516, ClinVar RCV001927977, REVEL 0.38, ESM-1b 0.00, Uncertain significance, Pigmentary pallidal degeneration
- L19I (p.Leu19Ile), gnomAD 20-3889155-C-A, REVEL 0.33, ESM-1b 0.00
- L19H (p.Leu19His), gnomAD 20-3889156-T-A, REVEL 0.25, ESM-1b 0.00
- L19P (p.Leu19Pro), rs752547236, gnomAD 20-3889156-T-C, REVEL 0.38, ESM-1b 0.00
- L19L (p.Leu19Leu), rs1258943762, gnomAD 20-3889157-C-T, CADD 6.79
- L12del (p.Leu12del), gnomAD 20-3889457-ACTG-A, CADD 20.80
- L19M (p.Leu19Met), gnomAD 20-3889464-C-A, REVEL 0.49, ESM-1b 1.00
- L19V (p.Leu19Val), rs778464738, gnomAD 20-3889464-C-G, REVEL 0.45, ESM-1b 0.00
- S20P (p.Ser20Pro), rs573337848, ClinGen CA9750469, ClinVar RCV003056792, REVEL 0.24, ESM-1b 0.00, Uncertain significance, Pigmentary pallidal degeneration
- S20F (p.Ser20Phe), gnomAD 20-3889154-ACT-A, CADD 22.10
- S20Y (p.Ser20Tyr), rs867957905, gnomAD 20-3889159-C-A, REVEL 0.17, ESM-1b 0.39
- S20S (p.Ser20Ser), rs1224931248, gnomAD 20-3889160-T-C, CADD 1.47
- S21P (p.Ser21Pro), rs764119764, ClinGen CA9750470, ClinVar RCV000992501, ClinVar RCV006367518, REVEL 0.22, ESM-1b 0.00, Conflicting interpretations, Inborn genetic diseases; not provided
- S21A (p.Ser21Ala), rs764119764, gnomAD 20-3889161-T-G, REVEL 0.20, ESM-1b 0.00
- S21Y (p.Ser21Tyr), gnomAD 20-3889162-C-A, REVEL 0.19, ESM-1b 0.28
- S21S (p.Ser21Ser), gnomAD 20-3889163-T-A, CADD 6.56
- G22R (p.Gly22Arg), rs1190185351, gnomAD 20-3889164-G-A, REVEL 0.19, ESM-1b 0.00
- G22W (p.Gly22Trp), gnomAD 20-3889164-G-T, REVEL 0.28, ESM-1b 0.00
- G22E (p.Gly22Glu), gnomAD 20-3889165-G-A, REVEL 0.15, ESM-1b 0.00
- G22G (p.Gly22Gly), rs144707315, gnomAD 20-3889166-G-T, CADD 5.03
- G22A (p.Gly22Ala), gnomAD 20-3889471-TGGGAG, CADD 32.00
- G22* (p.Gly22Ter), rs758064357, gnomAD 20-3889473-G-T, CADD 45.00
- G22V (p.Gly22Val), rs1352298565, gnomAD 20-3889474-G-T, REVEL 0.52, ESM-1b 0.00
- G22C (p.Gly22Cys), rs1214737069, gnomAD 20-3889479-G-T, REVEL 0.35, ESM-1b 0.00
- G22S (p.Gly22Ser), rs1214737069, gnomAD 20-3889479-G-A, REVEL 0.34, ESM-1b 0.00
- G22D (p.Gly22Asp), rs528149001, gnomAD 20-3889480-G-A, REVEL 0.40, ESM-1b 0.00
- L23V (p.Leu23Val), gnomAD 20-3889167-C-G, REVEL 0.14, ESM-1b 0.00
- L23I (p.Leu23Ile), gnomAD 20-3889167-C-A, REVEL 0.16, ESM-1b 0.00
- L23L (p.Leu23Leu), gnomAD 20-3889167-C-T, CADD 5.59
- L23P (p.Leu23Pro), gnomAD 20-3889168-T-C, REVEL 0.22, ESM-1b 0.00
- L23R (p.Leu23Arg), rs1475079321, gnomAD 20-3889168-T-G, REVEL 0.21, ESM-1b 0.00
- H24D (p.His24Asp), rs1481266018, gnomAD 20-3889168-T-TTG, CADD 16.80
- H24N (p.His24Asn), rs377348840, gnomAD 20-3889170-C-A, REVEL 0.21, ESM-1b 0.00
- H24Y (p.His24Tyr), rs377348840, gnomAD 20-3889170-C-T, REVEL 0.23, ESM-1b 0.00
- H24H (p.His24His), rs780163359, gnomAD 20-3889172-C-T, CADD 5.00
- H24Q (p.His24Gln), rs780163359, gnomAD 20-3889172-C-G, REVEL 0.34, ESM-1b 0.00
- H24P (p.His24Pro), gnomAD 20-3889504-G-GA, CADD 26.80
- H24R (p.His24Arg), gnomAD 20-3889507-A-G, REVEL 0.28, ESM-1b 0.00
- R25A (p.Arg25Ala), gnomAD 20-3889171-AC-A, CADD 17.40
- R25P (p.Arg25Pro), gnomAD 20-3889171-A-AC, CADD 19.40
- R25C (p.Arg25Cys), rs1441273132, gnomAD 20-3889173-C-T, REVEL 0.43, ESM-1b 0.00
- R25H (p.Arg25His), gnomAD 20-3889174-G-A, REVEL 0.34, ESM-1b 0.00
- R25L (p.Arg25Leu), rs910545691, gnomAD 20-3889174-G-T, REVEL 0.44, ESM-1b 0.00
- R25G (p.Arg25Gly), rs769849040, gnomAD 20-3889482-C-G, REVEL 0.35, ESM-1b 0.00
- R25W (p.Arg25Trp), rs769849040, gnomAD 20-3889482-C-T, REVEL 0.29, ESM-1b 0.00
- R25R (p.Arg25Arg), gnomAD 20-3889482-C-A, CADD 15.20
- R25Q (p.Arg25Gln), rs546381069, gnomAD 20-3889483-G-A, REVEL 0.33, ESM-1b 0.00
- R25S (p.Arg25Ser), gnomAD 20-3889503-C-A, REVEL 0.39, ESM-1b 0.00
- L26F (p.Leu26Phe), rs1178275314, ClinGen CA9750474, ClinVar RCV002724711, REVEL 0.25, ESM-1b 0.00, Uncertain significance, Inborn genetic diseases
- L26V (p.Leu26Val), rs1178275314, gnomAD 20-3889176-C-G, REVEL 0.28, ESM-1b 0.00
- L27I (p.Leu27Ile), rs1427393180, ClinGen CA408138674, ClinVar RCV002038366, ClinVar RCV004956180, REVEL 0.17, ESM-1b 0.00, Uncertain significance, Pigmentary pallidal degeneration; Inborn genetic diseases
- L27P (p.Leu27Pro), gnomAD 20-3889175-CCTTCT, CADD 17.80
- L27S (p.Leu27Ser), rs764033238, gnomAD 20-3889176-CT-C, CADD 16.10
- L27V (p.Leu27Val), gnomAD 20-3889179-C-G, REVEL 0.18, ESM-1b 0.00
- L27L (p.Leu27Leu), rs2090065892, gnomAD 20-3889181-C-T, CADD 3.28
- F28S (p.Phe28Ser), gnomAD 20-3889181-CT-C, CADD 14.70
- F28L (p.Phe28Leu), rs1460104819, gnomAD 20-3889182-T-C, REVEL 0.25, ESM-1b 0.00
- F28I (p.Phe28Ile), gnomAD 20-3889182-T-A, REVEL 0.26, ESM-1b 0.00
- F28F (p.Phe28Phe), rs753909037, gnomAD 20-3889184-C-T, CADD 9.13
- L29V (p.Leu29Val), rs755243523, gnomAD 20-3889185-C-G, REVEL 0.22, ESM-1b 0.00
- L29F (p.Leu29Phe), rs755243523, gnomAD 20-3889185-C-T, REVEL 0.17, ESM-1b 0.00
- L29P (p.Leu29Pro), gnomAD 20-3889186-T-C, REVEL 0.46, ESM-1b 0.00
- R30P (p.Arg30Pro), rs748578547, ClinGen CA9750479, ClinVar RCV003504252, REVEL 0.21, ESM-1b 0.00, Likely benign, Pigmentary pallidal degeneration
- R30H (p.Arg30His), gnomAD 20-3889182-TTCCTC, CADD 23.50
- R30C (p.Arg30Cys), rs778955722, gnomAD 20-3889188-C-T, REVEL 0.26, ESM-1b 0.00
- R30S (p.Arg30Ser), gnomAD 20-3889188-C-A, REVEL 0.23, ESM-1b 0.00
- R30L (p.Arg30Leu), rs748578547, gnomAD 20-3889189-G-T, REVEL 0.24, ESM-1b 0.00
- R30G (p.Arg30Gly), gnomAD 20-3889510-GC-G, CADD 25.10
- R30M (p.Arg30Met), gnomAD 20-3889513-G-T, REVEL 0.43, ESM-1b 0.63
- R30K (p.Arg30Lys), gnomAD 20-3889513-G-A, REVEL 0.32, ESM-1b 0.00
- R30R (p.Arg30Arg), gnomAD 20-3889514-G-A, CADD 14.10
- G31A (p.Gly31Ala), rs886044063, ClinGen CA10606301, ClinVar RCV000345784, ClinVar RCV001859692, REVEL 0.15, ESM-1b 0.00, Uncertain significance
- G31R (p.Gly31Arg), rs1410873147, gnomAD 20-3889191-G-C, REVEL 0.20, ESM-1b 0.00
- G31E (p.Gly31Glu), rs1310978152, gnomAD 20-3889192-G-A, REVEL 0.11, ESM-1b 0.00
Public PANK2 analysis runs
- PANK2 analysis run — PANK2 (611 variants) — completed 2026-10-30